At the forefront of pharmaceutical innovation, Virupaksha stands as a beacon of excellence in manufacturing high-purity Fluconazole, crucial for treating severe infections like cryptococcal meningitis. With an unwavering commitment to quality and safety, the company operates under stringent WHO-GMP guidelines, ensuring that every batch produced meets international standards for efficacy and purity.
Their state-of-the-art facilities are not only ISO 9001 certified—confirming their dedication to consistent quality management—but also ISO 14001 certified, highlighting their proactive approach to environmental sustainability in production processes. This meticulous attention to detail underscores Virupaksha’s mission: delivering pharmaceuticals that healthcare professionals can trust while contributing positively to the global community’s health outcomes.
Other Latest News
- Challenges to the Development of Emerging Therapies April 18, 2025 10:52 pm BioPharm International Emerging therapies provide new approaches to the treatment of many diseases and, in some cases, the potential for real cures. However, genetic medicines, cell therapies, multispecific antibodies, and other novel modalities are highly complex and present …
- How affirmative action ruling, federal funding cuts impact pharma and biotech April 18, 2025 9:17 pm Medical Marketing and Media It’s been nearly 18 months since the Supreme Court struck down the use of affirmative action in college admissions and the impact of that decision is being felt by the healthcare industry. Data released by the Association of American Medical Colleges …
- Fierce Pharma Asia—The latest on Trump's tariffs; Leqembi's EU approval; Kyowa Kirin's biologics plant April 18, 2025 5:27 pm Fierce Pharma The Trump administration is expected to announce tariffs on pharmaceuticals "in the next month or two," an official said. The European Commission has approved Eisai and Biogen's Leqembi in Alzheimer's disease. Kyowa Kirin has finished the …
- India Pharmaceutical Contract Sales Organizations Market Report 2025-2030: India's Pharma CSO Market To Reach $588.7M By 2030, Driven By Outsourcing & AI Integration April 18, 2025 10:10 am MENAFN (MENAFN- GlobeNewsWire - Nasdaq) Dublin, April 18, 2025 (GLOBE NEWSWIRE) -- The "India Pharmaceutical Contract Sales Organizations Market Size, Share & Trends Analysis Report By Service (Personal, Non-personal Promotion), By Therapeutic Area ( …
- Small Molecule Innovator API CDMO Market To Hit $47.14 Billion By 2030 At 6.38% CAGR, Driven By Outsourcing Trends And Drug Innovation April 18, 2025 9:24 am MENAFN (MENAFN- GlobeNewsWire - Nasdaq) CDMOs Expand Capabilities Amid Surge in Clinical Trials and Demand for Orphan Drugs and Novel Therapies Dublin, April 18, 2025 (GLOBE NEWSWIRE) -- The "Small Molecule Innovator API CDMO Market Size, Share & Trends …
- Trump tariffs could cause shortages of drugs and price hikes April 18, 2025 1:34 am AS Trump told reporters on Monday that in the “not too distant future” tariffs could hit pharmaceutical products coming into the country. Earlier in the day, his Department of Commerce filed a federal notice that it was beginning an investigation to determine …
- FYARRO Sets New Standard in Rare Oncology Market with Strong Growth Prospects | DelveInsight April 17, 2025 11:38 pm WFMZ - Pennsylvania FYARRO holds strong market potential, particularly in treating rare and aggressive cancers like PEComa, where treatment options are limited. As the first FDA-approved therapy for advanced PEComa, it addresses a critical unmet need. LAS VEGAS, April 17, …
- Infusion Pumps Market to Soar at a CAGR of ~10% by 2032, Owing to the Advancements in Technology and Increased Demand in Healthcare | DelveInsight April 17, 2025 5:00 pm EIN Presswire New York, USA, April 17, 2025 (GLOBE NEWSWIRE) -- Infusion Pumps Market to Soar at a CAGR of ~10% by 2032, Owing to the Advancements in Technology and Increased Demand in Healthcare | DelveInsight The infusion pumps market is experiencing significant …
- Oral Mucositis Market to Observe Stunning Growth During the Study Period (2020–2034) | DelveInsight April 17, 2025 5:00 pm EIN Presswire New York, USA, April 17, 2025 (GLOBE NEWSWIRE) -- Oral Mucositis Market to Observe Stunning Growth During the Study Period (2020–2034) | DelveInsight The growth of the oral mucositis market is expected to be mainly driven by increasing incidence of cancer …
- Healthcare Logistics Market Size To Hit USD 192.81 Billion By 2032, Growing At 9.07% CAGR – SNS Insider April 17, 2025 2:28 pm MENAFN (MENAFN- GlobeNewsWire - Nasdaq) According to Research by SNS Insider, The Global Healthcare Logistics Market Growth is Driven by Demand for Cold Chain, Pharma Distribution, and Supply Chain Resilience. Austin, April 17, 2025 (GLOBE NEWSWIRE) -- Healthcare …
- 04.17.25 -- STREAM Edition: Transform Your Drug Delivery And Manufacturing With Innovative Techniques April 17, 2025 2:22 pm Pharmaceutical Online Newsletter | April 17, 2025 Webinar | West Pharmaceutical Services, Inc. Gain insights pertinent to efficient and effective drug development to understand and execute a risk-based critical thinking approach related to injectable drug packaging and delivery …
- 9 Companies Hiring in Massachusetts April 17, 2025 1:29 pm BioSpace As the setting for the Genetown Hotbed, Massachusetts is one of the largest life sciences hubs in the United States. The state is known not only for its cell and gene therapy sector but also for its drug development pipeline, which represents 14.9% of the …
- Q1 Biopharma Layoffs Hit California, Massachusetts Hard April 17, 2025 1:29 pm BioSpace The majority of the first quarter’s biotech and pharma layoffs hit employees in the two most notable states for biopharma business—California and Massachusetts—according to BioSpace data. There were 22 rounds of layoffs in California and 17 in …
- Ritedose to double single-vial packaging capabilities with seventh Syntegon line April 17, 2025 11:55 am Packaging Gateway Ritedose, a sterile contract manufacturing organisation, is expanding its manufacturing facility with a seventh Syntegon-branded packaging line. This expansion will effectively double the company’s capacity to produce individually wrapped vial medications. …
- Big pharma pushes for European policy change as tariffs loom April 17, 2025 11:50 am Pharmaceutical Technology Pharmaceutical companies are demanding changes in European regulation as looming tariffs implemented by US President Donald Trump “threaten” billions of planned pharma investments on the continent. A group of 32 pharma companies sent a letter to European …
- Demand isn’t disappearing, it’s evolving: India’s GCC tech talent landscape 2024 report April 17, 2025 4:56 am ETCIO.com ● Generative AI, Platform Engineering, and Cybersecurity lead high-growth tech roles with up to 32% annual growth ● Bengaluru dominates strategic hiring in Defense, BFSI, and Construction; Hyderabad surges in Healthcare and AI-led roles Quess IT Staffing, …
- Podcast: What’s next for the pharma tariffs? April 16, 2025 8:24 pm Pharmaceutical Technology The US government has signalled a major shift in its trade policies in recent weeks, with several announcements detailing plans for import tariffs. While President Trump has made several announcements on tariffs since he took office, things accelerated on …
- Henlius 2025 Global R&D Day: Harnessing the Power of Innovation to Propel Global Strategy to New Heights April 16, 2025 7:24 pm The Laotian Times SHANGHAI, April 16, 2025 /PRNewswire/ — Henlius (2696.HK) held its 2025 Global R&D Day under the theme of “Collaborate to Create”. Senior executives from Henlius gathered with leading experts, scholars, and heads of innovation from across the …
- Why Pharma Risk Assessments Should Include 'Working Together Alone' April 16, 2025 7:14 pm Bioprocess Online By Andy O’Connor, ERA Sciences In the highly regulated world of pharmaceuticals and life sciences, risk isn’t just a numerical score — it’s a story of what might happen. Regulatory frameworks like ICH Q9 and ISO 31000 anchor our approaches to quality risk …
- Khaitan & Co, MakeMyTrip, and Shardul Amarchand Mangaldas rank top 3 on LinkedIn’s 2025 Top Midsize Companies India list April 16, 2025 3:00 pm The Hans India LinkedIn, the world’s largest professional network, today unveiled the 2025 Top Midsize Companies India list, featuring 15 companies with fewer than 5,000 employees globally and at least 250 employees in India, where professionals can build and grow their …
- Interview: Markus Schümmelfeder, CIO, Boehringer Ingelheim April 16, 2025 2:37 pm Computer Weekly Markus Schümmelfeder has spent more than a decade looking for ways to help biopharmaceutical giant Boehringer Ingelheim exploit digital and data. He joined the company in February 2014 as corporate vice-president in IT and became CIO in April 2018. “It was …
- Generic Drugs Market Size Worth $728.64 Bn by 2034 | Driven by Affordability, Patent Expirations, and Government Support April 16, 2025 2:30 pm EIN Presswire Ottawa, Precedence Research, April 16, 2025 (GLOBE NEWSWIRE) -- According to Precedence Research, the worldwide generic drugs market size was valued at USD 445.62 billion in 2024 and is projected to grow from USD 468.08 billion in 2025 to USD 728.64 …
- The GLP-1 drug shortage is over. What’s next for the compounders? April 16, 2025 1:41 pm Pharmaceutical Technology “I am taking compounded semaglutide that I ordered online, but I don’t know how long I will have access to it.” That was what one anonymous patient told Pharmaceutical Technology on an online compounded semaglutide forum on Reddit with over 10,000 members. …
- Manufacturing Business News: Emotionally Expressive Robots, a Pharmaceutical Importation Investigation and Other Headlines April 16, 2025 5:28 am IndustryWeek While we have a great staff of dedicated editors here at IndustryWeek, we can’t write about everything. So, here’s a roundup of news from our parent company Endeavor Business Media’s many news brands. Tariff Turbulence and the Impacts on Industrial …
- J&J projects $400m tariff hit but raises sales outlook April 15, 2025 8:20 pm Pharmaceutical Technology Johnson & Johnson Innovative Medicine (J&J) addressed the potential impact of pharmaceutical tariffs during its Q1 2025 earnings call, as the US government intensifies its scrutiny of foreign drug supply chains. The company’s chief financial …